Drug administration method

• US 7,427,607 B2
• Filed: 02/18/2003
• Issued: 09/23/2008
• Est. Priority Date: 02/20/2002
• Status: Expired due to Term

• Current Assignee: NEXT 21 K.K
• Original Assignee: NEXT 21 K.K
• Inventors: Suzuki, Shigeki
• Primary Examiner(s): Richter; Johann
• Assistant Examiner(s): ALSTRUM ACEVEDO, JAMES HENRY
• Application Number:
  US10/505,205
• Publication Number:
  US 20050123485A1
• Time in Patent Office: 2,044 Days
• Field of Search: 424/43, 424/46, 424/401, 424/489, 514/2, 514/23, 514/44, 514/54, 514/55, 514/57, 514/59
• US Class Current: 514/57
• CPC Class Codes: A61B 17/00491 Surgical glue applicators surgical adhesives A61L24/00; two-component delivery syringes A61M5/19
• CPC Class Codes: A61K 9/12 Aerosols; Foams A61K9/0043, A61K9/0056, A61K9/006, A61K9/0073 take precedence; spray-films A61K9/7015
• CPC Class Codes: A61M 13/00 Insufflators for therapeutic or disinfectant purposes , i.e. devices for blowing a gas, powder or vapour into the body hand-held units in which gas flow is produced by muscular energy at the moment of use B05B11/062
• CPC Class Codes: A61M 15/025 Bubble jet droplet ejection devices
• CPC Class Codes: A61M 2202/066 made from a compacted product by abrading
• CPC Class Codes: A61M 2205/3331 Pressure; Flow
• CPC Class Codes: A61M 2205/7518 bacterial

Abstract

A method of administering a drug whereby a fine drug powder can be accurately administered to a target site (in particular, a target site in the body cavity) via fluidization and spraying with a gas by using a micro tube. Concerning the administration mode, in particular, the drug alone or a biopolymer is administered or the biopolymer is employed as a carrier in the above method. More specifically speaking, a method of administering a fine drug powder which comprises finely milling one or more types fine particles of the drug and/or the biopolymer, blending them each other, fluidizing the blend with a gas, then transporting the fluidized matter in a micro tube by the gas stream and spraying the fine drug powder from the tip of the micro tube toward the target site. Further, an administration method which comprises concentrically providing a capillary tube in the micro tube, supplying an aqueous solution of the drug and/or the biopolymer from the capillary tube into the gas stream and then mixing it with other fine particles of the drug and/or the biopolymer under transportation by the gas.

Claims

1. A method for administering a biopolymer having hemostatic or adhesion preventing functions, comprising the steps of:

fluidizing fine particles of the biopolymer having hemostatic or adhesion preventing functions with a gas to prepare a homogenous mixed-phase fluid;

transferring the mixed-phase fluid through at least one micro-tube by flowing the gas;

mixing a liquid with the mixed-phase fluid, the liquid being selected from the group consisting of a saline solution, an infusion solution, an aqueous solution of a drug and an aqueous solution of a biopolymer;

the liquid being injected into the micro-tube thorough at least one inner tube so that the liquid is mixed with the mixed-phase fluid, wherein the inner tube is configured to be within the micro-tube;

spraying the mixed liquid and the mixed-phase fluid toward a target site from an open tip of the micro-tube;

wherein the mixed liquid and the mixed-phase fluid become a gel compound after the liquid and the mixed-phase fluid are mixed;

whereby the fine particles of the biopolymer are capable of being sprayed as a gel compound toward the targct site to provide a seal upon the target site.

2. The method in accordance with claim 1, wherein the biopolymer is carboxymethyl cellulose.

3. The method in accordance with claim 1, wherein the biopolymer is carboxymethyl cellulose and the liquid is cationic cellulose aqueous solution.

4. The method in accordance with claim 1, wherein the step of fluidizing fine particles of a biopolymer with a gas is

a step of fluidizing a finely powdered drug and fine particles of a biopolymer with a gas to prepare a homogenous mixed-phase fluid.

5. The method in accordance with claim 1, wherein the liquid comprises an aqueous solution of drug.

6. The method in accordance with claim 1, wherein the biopolymer comprises at least two types of biopolymers, the two types of biopolymers being a combination of an anionic biopolymer and a cationic biopolymer.

7. The method in accordance with claim 1, wherein the gas is carbon dioxide gas or nitrogen gas.

8. The method in accordance with claim 1, wherein the liquid comprises fibrinogen aqueous solution and thrombin aqueous solution.

9. A method for administering a biopolymer having hemostatic or adhesion preventing functions, comprising the steps of:

fluidizing fine particles of the biopolymer having hemostatic or adhesive preventing functions with a gas to prepare a homogenous mixed-phase fluid, wherein the biopolymer comprises at least two types of biopolymers, the two types of biopolymers being a combination of an anionic biopolymer and a cationic biopolymer;

transferring the mixed-phase fluid through at least onc micro-tube by flowing the gas;

mixing a liquid with the mixed-phase fluid, the liquid being selected from the group consisting of a saline solution, an infusion solution, an aqueous solution of a drug and an aqueous solution of a biopolymer;

the liquid being injected into the micro-tube thorough at least one inner tube so that the liquid is mixed with the mixed-phase fluid, wherein the inner tube is contained within the micro-tube;

spraying the mixed liquid and the mixed-phase fluid toward a target sitc from an open tip of the micro-tube;

wherein the mixed liquid and the mixed-phase fluid become a gel compound after the liquid and the mixed-phase fluid are mixed;

whereby the fine particles of the biopolymer are capable of being sprayed as a gel compound toward the target site.

10. A method for administering a biopolymer having hemostatic or adhesion preventing functions, comprising the steps of:

fluidizing fine particles of the biopolymer selected from the group consisting carboxymethyl celluloses, carboxyethyl celluloses, oxycelluloses, agaroses, chitins, chitosans, hyluronic acids, starches, glycogens, alginates, pectins, dextrans, chondroitin sulfates, gelatins and collagens with a gas to prepare a homogenous mixed-phase fluid;

transferring the mixed-phase fluid through at least one micro-tube by flowing the gas;

mixing a liquid with the mixed-phase fluid, the liquid being selected from the group consisting of a saline solution, an infusion solution, an aqueous solution of a drug and an aqueous solution of a biopolymer;

thc liquid being injected into the micro-tube thorough at least one inner tube so that the liquid is mixed with the mixed-phase fluid, wherein the inner tube is configured to be within the micro-tube;

spraying the mixed liquid and the mixed-phase fluid toward a target site from an open tip of the micro-tube;

wherein the mixed liquid and the mixed-phase fluid become a gel compound after the liquid and the mixed-phase fluid are mixed;

whereby the fine particles of the biopolymer are capable of being sprayed as a gel compound toward the target site to provide a seal upon the target site.